2/16/2026CSPC's Long-Acting Ropivacaine Injection Cleared for Clinical Trials i...

2/16/2026CStone's Trispecific Antibody CS2009 Receives FDA IND Clearance, Ente...

2/12/2026Ascletis Picks Oral Amylin Agonist ASC36 for Obesity Development, Plan...

2/12/2026RemeGen Advances PD-1/VEGF BsAb RC148 Into Phase 3 Trials

2/12/2026Lilly's Jaypirca Approved in China for Previously Treated CLL and SLL ...

2/12/2026Lilly China's Mounjaro Approved for Type 2 Diabetes Monotherapy

2/11/2026Eli Lilly's Omvoh Approved in China for Crohn's Disease and Ulcerative...

2/11/2026Betta Pharma Wins China Approval for Pertuzumab Biosimilar in Breast C...

2/11/2026Shiling Pharma Targets 2028 for Nasal Spray Version of Wegovy Obesity ...

2/11/2026China Eyes Approval for Russian Cancer Vaccine 'Enteromix'

2/11/2026GSK's RSV Vaccine Arexvy Moves Forward in China

2/10/2026Weekly China Regulatory Roundup: EGFR, TROP2 Approvals and Broad IND A...

2/10/20263D Medicines Advances Envafolimab Toward Full Market Approval in China

2/9/2026J&J Wins China Approval Expanding Subcutaneous Daratumumab Use

2/9/2026InnoCare Wins China IND Clearance for VAV1 Molecular Glue Degrader ICP...

2/9/2026Ascletis Begins U.S. Phase II Trial of Oral GLP-1R Agonist ASC30 for T...

2/9/2026GenSci Advances Autoimmune Pipeline as NMPA Clears First IND for GenSc...

2/7/2026Delonix Secures IND Clearance for Novel MenB Vaccine DX-104 in China ...

2/6/2026Kelun-Biotech Expands Breast Cancer Indications of sac-TMT in China

2/6/2026Merck's Keytruda Wins New China Approval for Frontline Endometrial Can...

2/6/2026Everest Medicines Gains Chinese Approval for VELSIPITY® in UC

2/5/2026Fosun Secures Priority Review in China for Luvometinib's New Indicatio...

2/5/2026Ascentage Secures China IND Clearance for Next-Gen BTK Degrader APG-32...

2/4/2026Innovent Advances IL-15 Antibody IBI3013 Into Clinical Trials for Viti...

2/4/2026China Clears BeBetter Med Dual-Target siRNA Therapy for Combined Hyper...

2/4/2026Chia Tai Tianqing's Anlotinib New Indication Application Rejected

2/4/2026Almirall's Seysara Approved in China for Moderate-to-Severe Acne

2/4/2026Bayer's Nubeqa Gains Third Approval in China for Advanced Prostate Can...

2/4/2026CMS Gets Green Light from NMPA to Launch Trials for Novel Kidney Disea...

2/3/2026HSG Completes Global Acquisition of Avelox and Launches Anti-Infective...

Page:1/22 Total number of articles:649: [First][<<] [1] [2] [3] [4] [5] [>>] [End]